US Corporate Distress Financial Stress SEC Filings — February 16, 2026

17-02-2026

MAINZ BIOMED N.V. filed a multi-item Form 8-K on February 17, 2026, disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), departure/election of directors or officers and compensatory arrangements (Item 5.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). Specific details including transaction values, share counts, financial impacts, dollar amounts, or quantitative metrics are NOT_DISCLOSED. The combination of potential strategic agreement alongside equity issuances and rights changes suggests mixed implications, but lacks quantification for assessment.

17-02-2026

EKSO Bionics Holdings, Inc. filed a multi-item Form 8-K on February 17, 2026, disclosing events under Items 1.01 (Entry into a Material Definitive Agreement), 2.02 (Results of Operations and Financial Condition), 3.02 (Unregistered Sales of Equity Securities), 3.03 (Material Modifications to Rights of Security Holders), 5.01 (Changes in Control of Registrant), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), 5.03 (Amendments to Articles of Incorporation or Bylaws), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, or quantitative impacts are disclosed. The combination of control changes, equity sales, and governance modifications suggests potential strategic shifts, dilution risks, and operational updates without further details provided.

17-02-2026

Portland General Electric Co /OR/ filed a Form 8-K on 2026-02-17 reporting multiple material items: entry into a material definitive agreement (Item 1.01), results of operations and financial condition (Item 2.02), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item filing likely combining earnings release with new agreement and financing details. Specific transaction values, financial metrics, period-over-period changes, guidance, or impacts are NOT_DISCLOSED.

17-02-2026

Greenpro Capital Corp. filed an 8-K on February 17, 2026, under Item 1.01 disclosing entry into a material definitive agreement. Item 9.01 includes financial statements and exhibits. No specific details on the agreement terms, transaction value, financial impacts, or other metrics are disclosed.

17-02-2026

The company filed an 8-K on February 17, 2026 (AccNo: 0000075594-26-000004), reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details regarding the nature of the agreement, transaction size, financial impacts, or other events are disclosed in the provided information. This represents a multi-item filing with mandatory disclosure for Item 1.01.

17-02-2026

Cineverse Corp. filed a Form 8-K on 2026-02-17 reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details, dollar values, financial metrics, positive or negative impacts, or other quantitative data are provided in the filing summary.

17-02-2026

Matthews International Corp filed an 8-K on February 17, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific transaction details, dollar values, strategic impacts, or financial metrics are disclosed.

17-02-2026

nVent Electric plc filed an 8-K on February 17, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement, transaction size, parties, financial impacts, or quantitative metrics are provided.

17-02-2026

TG-17, Inc. filed a Form 8-K on February 17, 2026, under Item 1.01 disclosing entry into a material definitive agreement and Item 9.01 providing financial statements and exhibits. No details on the agreement's nature, counterparties, terms, value, or financial impacts are disclosed. This is a multi-item mandatory filing with no quantitative metrics or period-over-period comparisons provided.

17-02-2026

BioRestorative Therapies, Inc. filed an 8-K on 2026-02-17 reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, transaction terms, financial impacts, or quantitative metrics disclosed in the provided information. No positive or negative performance metrics, period-over-period changes, or guidance revisions are mentioned.

17-02-2026

Bioxytran, Inc. filed an 8-K on 2026-02-17 disclosing Item 1.01 Entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, events, financial impacts, or quantitative metrics were provided in the filing summary. No positive or negative metrics were mentioned.

17-02-2026

Applied Digital Corp. filed an 8-K on February 17, 2026, reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No quantitative details, financial impacts, positive or negative metrics, or period-over-period comparisons are provided in the available information.

17-02-2026

TE Connectivity plc filed an 8-K on February 17, 2026, reporting under Item 1.01 the entry into a material definitive agreement, under Item 1.02 the termination of a material definitive agreement, and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No quantitative details, financial impacts, positive or negative metrics, or directional changes were disclosed.

17-02-2026

Trinseo PLC filed a Form 8-K on February 17, 2026 (AccNo: 0001104659-26-015648), reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 a Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, transaction value, financial impacts, or performance metrics disclosed in the provided information. No quantitative data, period-over-period comparisons, or scheduled events are mentioned.

17-02-2026

Kennedy-Wilson Holdings, Inc. filed an 8-K on February 17, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details on the nature of the agreement, events, or exhibits are provided in the filing summary. No quantitative financial metrics, period-over-period comparisons, or directional impacts are mentioned.

17-02-2026

Vulcan Materials Company filed an 8-K on February 17, 2026 (AccNo: 0001140361-26-005605), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely related to earnings or operational updates, but no specific financial metrics, positive or negative changes, guidance, or transaction details are disclosed in the provided information. All quantitative data and performance comparisons remain NOT_DISCLOSED.

17-02-2026

AIR INDUSTRIES GROUP filed a Form 8-K on February 17, 2026, reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with both mandatory (Items 1.01, 3.02) and voluntary (Item 7.01) disclosures. No quantitative details such as transaction values, share counts, financial impacts, or strategic context are disclosed.

17-02-2026

XFLH Capital Corp filed a Form 8-K on February 17, 2026, reporting multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This multi-item filing signals significant corporate actions including a material agreement and potential equity dilution, but no specific transaction values, financial impacts, or further details are disclosed. No positive or negative metrics are provided, resulting in informational disclosure without directional bias.

17-02-2026

Blue Bird Corp filed an 8-K on 2026-02-17 disclosing Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, financial impacts, or metrics are provided in the filing summary. No positive, negative, or flat performance metrics are disclosed.

17-02-2026

Playtika Holding Corp. filed an 8-K on February 17, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 references financial statements and exhibits. No specific transaction details, values, or impacts are disclosed.

17-02-2026

Intellinetics, Inc. filed a Form 8-K on 2026-02-17 disclosing multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing for most items, but no specific details on the agreement, obligation size, officer changes, dollar values, strategic rationale, or quantitative impacts are provided. No positive, negative, or flat metrics are mentioned.

17-02-2026

Invech Holdings, Inc. filed a Form 8-K on February 17, 2026, disclosing multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.01 (Changes in Control of Registrant), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), and 9.01 (Financial Statements and Exhibits). No specific details on transaction values, parties involved, financial impacts, or changes are provided in the filing summary. This multi-item filing indicates a potentially transformative corporate event such as a merger or acquisition leading to control changes, but lacks quantitative data for assessment.

17-02-2026

VisionWave Holdings, Inc. filed a Form 8-K on 2026-02-17 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 includes financial statements and exhibits. No details on the agreement terms, transaction value, financial impacts, strategic rationale, or any quantitative metrics are disclosed.

17-02-2026

Masimo Corp filed a Form 8-K on February 17, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details provided on the agreement's nature, parties, terms, financial impacts, or any quantitative metrics such as transaction value, revenue effects, or guidance changes. No positive or negative metrics are disclosed, resulting in purely informational disclosure.

17-02-2026

Kindly MD, Inc. filed a Form 8-K on February 17, 2026, reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, dollar values, or financial metrics disclosed in the provided information. No positive or negative performance metrics are mentioned.

17-02-2026

JFB Construction Holdings filed a Form 8-K on February 17, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 3.02 unregistered sales of equity securities, Item 8.01 other events, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific transaction details, dollar values, or financial metrics disclosed in the provided information. No positive or negative performance metrics are mentioned.

17-02-2026

XTI Aerospace, Inc. filed a Form 8-K on February 17, 2026, disclosing under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 3.03 material modifications to rights of security holders, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No specific transaction details, dollar values, financial metrics, positive or negative impacts, or period-over-period comparisons are disclosed in the provided filing summary. This is a multi-item filing likely involving financing or restructuring with potential balance sheet and shareholder implications.

17-02-2026

Xerox Holdings Corp filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-053333), reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, transaction terms, financial impacts, or metrics provided in the filing summary. No quantitative data, period-over-period comparisons, or scheduled events are disclosed.

17-02-2026

C2 Blockchain, Inc. filed a Form 8-K on February 17, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and under Item 3.02 unregistered sales of equity securities. Item 9.01 provides financial statements and exhibits. No specific transaction values, parties, financial impacts, or other quantitative details are disclosed.

17-02-2026

Apple iSports Group, Inc. filed an 8-K on 2026-02-17 disclosing under Item 1.01 its entry into a material definitive agreement. No details regarding the nature of the agreement, counterparties, dollar value, financial terms, or strategic implications are provided in the filing summary. This is a single-item filing with no quantitative metrics, guidance changes, or scheduled events mentioned.

17-02-2026

AIxCrypto Holdings, Inc. filed a Form 8-K on February 17, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 discloses financial statements and exhibits. No quantitative details, transaction values, financial impacts, or specific changes are provided in the filing summary.

17-02-2026

P3 Health Partners Inc. filed a Form 8-K on February 17, 2026, disclosing under Item 1.01 its entry into a material definitive agreement. Item 9.01 reports financial statements and exhibits. No details on the agreement's terms, parties, value, financial impacts, or strategic rationale are provided.

17-02-2026

AST SpaceMobile, Inc. filed a multi-item 8-K on February 17, 2026, reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). While Items 1.01 and 2.03 suggest potential access to capital or financing, Item 3.02 indicates equity securities issuance that could dilute existing shareholders. No specific transaction values, terms, financial metrics, or impacts are disclosed.

17-02-2026

Q32 Bio Inc. filed a Form 8-K on February 17, 2026 (AccNo: 0001193125-26-054711), reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing for Item 1.01, with no specific details on the agreement, events, transaction size, financial impacts, or metrics provided in the available information.

17-02-2026

Safe & Green Development Corp filed a Form 8-K on February 17, 2026, disclosing entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). This multi-item filing signals a significant transaction involving financing or partnership activity, but no specific dollar values, share counts, or financial impacts are disclosed. No positive or negative metrics are provided, resulting in no directional bias.

17-02-2026

Howard Hughes Holdings Inc. filed a Form 8-K on February 17, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 1.02 termination of a prior material definitive agreement, representing a multi-item filing with mixed implications. Item 8.01 discloses other events, while Item 9.01 includes financial statements and exhibits. No specific details, transaction values, financial impacts, or quantitative metrics are disclosed.

17-02-2026

NATURAL HEALTH TRENDS CORP filed an 8-K on 2026-02-17 (AccNo: 0001437749-26-004352, Size: 247 KB) reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the agreement, events, transaction value, parties, financial impacts, or metrics are disclosed. This is a multi-item mandatory filing with no period-over-period comparisons or quantitative data provided.

17-02-2026

CORE MOLDING TECHNOLOGIES INC filed an 8-K on 2026-02-17 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 includes financial statements and exhibits. No specific details on the agreement's nature, parties, value, financial impact, or strategic implications are provided.

17-02-2026

Awaysis Capital, Inc. filed an 8-K on February 17, 2026, disclosing under Item 1.01 the entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 references financial statements and exhibits. No specific details on transaction terms, dollar values, strategic rationale, or financial impacts are disclosed.

17-02-2026

BullFrog AI Holdings, Inc. filed an 8-K on 2026-02-17 disclosing under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Item 9.01 includes Financial Statements and Exhibits. No additional financial metrics, reasons for delisting, or quantitative impacts are disclosed.

17-02-2026

Eos Energy Enterprises, Inc. filed a Form 8-K on 2026-02-17 reporting entry into a material definitive agreement under Item 1.01. Item 9.01 discloses financial statements and exhibits related to the agreement. No specific details on the agreement's parties, terms, value, financial impacts, or strategic context are provided.

17-02-2026

Atossa Therapeutics, Inc. filed an 8-K on 2026-02-17 under Item 3.01, providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, transaction values, or additional details such as reasons for delisting, dollar impacts, or guidance changes were disclosed. This represents a material negative event with no offsetting positive information provided.

17-02-2026

Mereo BioPharma Group plc filed a Form 8-K on 2026-02-17 under Item 3.01 announcing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing from the US market. No quantitative financial metrics, transaction values, or additional details such as revenue impacts, balance sheet effects, or guidance changes were disclosed.

17-02-2026

Equity Bancshares Inc filed a Form 8-K on 2026-02-17 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), with Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure of a material event involving a new agreement and financial obligation. No quantitative details, transaction values, parties, impacts, or performance metrics (positive, negative, or flat) are disclosed.

• ·AccNo: 0001193125-26-054930
• ·File Size: 298 KB

17-02-2026

Inuvo, Inc. filed an 8-K on February 17, 2026, disclosing under Item 1.01 entry into a Material Definitive Agreement. Item 9.01 references Financial Statements and Exhibits. No specific details on the agreement, transaction terms, financial impacts, or quantitative metrics are provided.

17-02-2026

Digital Brands Group, Inc. filed a multi-item Form 8-K on February 17, 2026 (AccNo: 0001493152-26-007183), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No quantitative data, transaction details, financial impacts, or specific agreements are disclosed in the provided filing summary. Critical details such as dollar values, share counts, and strategic context remain NOT_DISCLOSED.

17-02-2026

PSQ Holdings, Inc. filed a Form 8-K on 2026-02-17 under Accession No. 0001104659-26-016552 (297 KB), reporting a notice of delisting or failure to satisfy a continued listing rule or standard under Item 3.01. The multi-item filing also includes Item 2.02 on results of operations and financial condition and Item 9.01 for financial statements and exhibits. No specific financial metrics, reasons for delisting, transaction values, or quantitative impacts are disclosed.

17-02-2026

Leidos Holdings, Inc. filed an 8-K on February 17, 2026, under Item 1.01 disclosing entry into a material definitive agreement and under Item 2.03 announcing the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No quantitative details, financial impacts, or strategic context are disclosed.

17-02-2026

HOOKER FURNISHINGS Corp filed an 8-K on February 17, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction terms, financial metrics, or impacts are disclosed in the provided filing summary. This is a multi-item mandatory disclosure.

17-02-2026

Auddia Inc. filed a Form 8-K on 2026-02-17 reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 a Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details, terms, financial metrics, or quantitative impacts disclosed in the provided information. No positive or negative metrics are mentioned.

17-02-2026

Healthy Choice Wellness Corp. filed an 8-K on February 17, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, with Item 9.01 providing financial statements and exhibits. No specific transaction details, dollar values, share counts, or financial impacts are disclosed. This is a multi-item filing with no period-over-period metrics or comparisons provided.

17-02-2026

DIRTT Environmental Solutions Ltd filed a Form 8-K on February 17, 2026 (AccNo: 0001193125-26-055157), reporting entry into a material definitive agreement under Item 1.01, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02, and Regulation FD disclosure under Item 7.01. This is a multi-item filing with no specific transaction details, financial metrics, dollar values, or named individuals disclosed. No positive or negative performance metrics were provided, preventing assessment of directional impact.

17-02-2026

GeoVax Labs, Inc. filed an 8-K on February 17, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02. Regulation FD disclosure is provided under Item 7.01, accompanied by financial statements and exhibits under Item 9.01. No quantitative details such as transaction values, share counts, financial impacts, or period-over-period metrics are disclosed.

17-02-2026

CIMG Inc. filed a Form 8-K on February 17, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, and under Item 3.02 unregistered sales of equity securities. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, share counts, or financial impacts are disclosed.

• ·Multi-item 8-K filing (Items 1.01, 2.03, 3.02, 9.01)

17-02-2026

Bally's Corp filed an 8-K on February 17, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No quantitative details, transaction terms, dollar values, or financial impacts are disclosed.